Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158907 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163660 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL2163401 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL16431159 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL910497 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL548521 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL1240474 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL158906 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL9696115 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 | |
| SCHEMBL415112 | 1.00 | FAAH (0.54) | FAAHTRPV1TSHRTERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4368657-A1 | PH-RESPONSIVE LIPID DERIVATIVE | NOF Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| US-20240132628-A1 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NEUBASE THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| EP-4332146-A1 | POLYTHIOPHENE COMPOUND AND CONDUCTIVE MATERIAL COMPOSITION | OSAKA UNIVERSITY (JP) | 2024-03-06 | — | — | EP | disclosed |
| EP-4263491-A2 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NeuBase Therapeutics, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230242692-A1 | COMPOSITION AND CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
| US-20230174985-A1 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NEUBASE THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-20230103631-A1 | PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS | SANOFI (FR) | 2023-04-06 | — | — | US | disclosed |
| CN-115884982-A | Peptides as selective GIP receptor agonists | 赛诺菲 | 2023-03-31 | — | — | CN | disclosed |
| US-11603530-B2 | Modified peptide nucleic acid compositions | NEUBASE THERAPEUTICS, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| EP-4127228-A2 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NeuBase Therapeutics, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20070142534-A1 | Process for the preparation of polyolefin nanocomposites | POLYMERS AUSTRALIA PTY. LIMITED (AU) | 2007-06-21 | — | — | US | disclosed |
| WO-2007039435-A1 | DISPERSING AGENTS IN COMPOSITES | POLYMERS CRC LIMITED (AU) | 2007-04-12 | — | — | WO | disclosed |
| EP-1575873-A1 | PROCESS FOR THE PREPARATION OF POLYOLEFIN NANOCOMPOSITES | Polymers Australia PTY Limited (AU) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004041721-A1 | PROCESS FOR THE PREPARATION OF POLYOLEFIN NANOCOMPOSITES | POLYMERS AUSTRALIA PTY. LIMITED (AU) | 2004-05-21 | — | — | WO | disclosed |
| US-6562804-B2 | For stimulating hair growth in a mammal | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-05-13 | — | — | US | disclosed |
| US-20020172657-A1 | Hair-growing agent | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-11-21 | — | — | US | disclosed |
| EP-1232740-A2 | Hair-growing agent | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-08-21 | — | — | EP | disclosed |
| US-4665201-A | ANTITUMOR AGENTS | SUNTORY, LIMITED (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0080570-B1 | AILANTHONE DERIVATIVES | SUNTORY LIMITED (JP) | 1986-12-17 | — | — | EP | disclosed |
| EP-0080570-A2 | Ailanthone derivatives | SUNTORY LIMITED (JP) | 1983-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020172657-A1 | Hair-growing agent | PHOSPHO1, PLD1, SGMS1 | FAAH 93/4885TRPV1 1722/4885TSHR 2886/4885 |
| US-20230174985-A1 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | TARDBP, SARNP, SNRPE | FAAH 4761/4885TRPV1 4600/4885TSHR 1773/4885 |
| US-11603530-B2 | Modified peptide nucleic acid compositions | TARDBP, SARNP, SNRPE | FAAH 4761/4885TRPV1 4600/4885TSHR 1773/4885 |
| US-20230103631-A1 | PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS | GIPR, GLP1R, GPR119 | FAAH 555/4885TRPV1 117/4885TSHR 145/4885 |
| US-20240132628-A1 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | SMN1; SMN2, POLRMT, TARDBP | FAAH 3939/4885TRPV1 4376/4885TSHR 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.